Yeast-free diet
Yeast-free diet has been studied in 1 paper since 2024: 1 trial in people. The newest paper, Oct 26, 2024: “Assessing the impact of a wheat flour and baker's yeast restricted diet vs. calorie restriction in non-alcoholic fatty liver disease patients”.
1 paper studies it3 findingsUpdated
See all 1 papers on yeast-free diet
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“both the WFFD and YFD groups exhibited a noteworthy reduction in body mass index (BMI) and triglyceride (TG) levels when compared to a standard diet that only involved calorie restriction.”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave yeast-free diet to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
| Trial6 months | 243 people139 women and 104 menAdult individuals diagnosed with NAFLD | Archives of medical science : AMS, Oct 26, 2024 |
What did studies of yeast-free diet find?
3Studies of yeast-free diet measured 3 outcomes: hepatic steatosis, hepatic steatosis and body mass index.
Hepatic steatosis
downin humans1
1 study
Hepatic steatosis
downin humans1
Yeast-free diet decreases hepatic steatosis in humans after 6 months compared with standard diet.
“While no difference was found in terms of fatty liver at 3 months in the pairwise comparisons between the diet groups, statistical significance was observed between the standard diet and both WFFD and YFD at 6 months.”
Human trialafter 6 months compared with standard diet6 monthsn = 243
Archives of medical science : AMS
Hepatic steatosis
downin humans1
1 study
Hepatic steatosis
downin humans1
Yeast-free diet decreases hepatic steatosis in NAFLD patients.
“Furthermore, a notable reduction in the severity of liver steatosis was seen in these groups (p < 0.05).”
Human trialin NAFLD patients6 months
Archives of medical science : AMS
Body mass index
downin humans1
1 study
Body mass index
downin humans1
Yeast-free diet decreases body mass index in NAFLD patients.
“both the WFFD and YFD groups exhibited a noteworthy reduction in body mass index (BMI) and triglyceride (TG) levels when compared to a standard diet that only involved calorie restriction.”
Human trialin NAFLD patients6 months
Archives of medical science : AMS